Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.

Love MS, Millholland MG, Mishra S, Kulkarni S, Freeman KB, Pan W, Kavash RW, Costanzo MJ, Jo H, Daly TM, Williams DR, Kowalska MA, Bergman LW, Poncz M, DeGrado WF, Sinnis P, Scott RW, Greenbaum DC.

Cell Host Microbe. 2012 Dec 13;12(6):815-23. doi: 10.1016/j.chom.2012.10.017.

2.

Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum.

Malmquist NA, Moss TA, Mecheri S, Scherf A, Fuchter MJ.

Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16708-13. doi: 10.1073/pnas.1205414109. Epub 2012 Sep 24.

3.

Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum.

McMorran BJ, Wieczorski L, Drysdale KE, Chan JA, Huang HM, Smith C, Mitiku C, Beeson JG, Burgio G, Foote SJ.

Science. 2012 Dec 7;338(6112):1348-51. doi: 10.1126/science.1228892.

4.

A class of potent antimalarials and their specific accumulation in infected erythrocytes.

Wengelnik K, Vidal V, Ancelin ML, Cathiard AM, Morgat JL, Kocken CH, Calas M, Herrera S, Thomas AW, Vial HJ.

Science. 2002 Feb 15;295(5558):1311-4.

5.

Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA).

Satish PVV, Sunita K.

BMC Complement Altern Med. 2017 Sep 11;17(1):458. doi: 10.1186/s12906-017-1958-y.

6.

Beneficial effect of aurothiomalate on murine malaria.

Alesutan I, Bobbala D, Qadri SM, Estremera A, Föller M, Lang F.

Malar J. 2010 May 7;9:118. doi: 10.1186/1475-2875-9-118.

7.

[Erythrocytes infected by Plasmodium falciparum activate human platelets].

Polack B, Peyron F, Sheick Zadiuddin I, Kolodié L, Ambroise-Thomas P.

C R Acad Sci III. 1990;310(12):577-82. French.

PMID:
2142012
8.

Malaria parasite clearance.

White NJ.

Malar J. 2017 Feb 23;16(1):88. doi: 10.1186/s12936-017-1731-1. Review. Erratum in: Malar J. 2017 May 10;16(1):194.

9.

Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.

Wilson DW, Goodman CD, Sleebs BE, Weiss GE, de Jong NW, Angrisano F, Langer C, Baum J, Crabb BS, Gilson PR, McFadden GI, Beeson JG.

BMC Biol. 2015 Jul 18;13:52. doi: 10.1186/s12915-015-0162-0.

10.

Protective activity of biflavanones from Garcinia kola against Plasmodium infection.

Konziase B.

J Ethnopharmacol. 2015 Aug 22;172:214-8. doi: 10.1016/j.jep.2015.06.038. Epub 2015 Jun 27.

PMID:
26129936
11.

[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].

Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.

Sante. 2008 Jan-Mar;18(1):43-7. doi: 10.1684/san.2008.0103. French.

12.

Blood shizonticidal activities of phenazines and naphthoquinoidal compounds against Plasmodium falciparum in vitro and in mice malaria studies.

de Souza NB, de Andrade IM, Carneiro PF, Jardim GA, de Melo IM, da Silva Júnior EN, Krettli AU.

Mem Inst Oswaldo Cruz. 2014 Aug;109(5):546-52. Epub 2014 Aug 5.

13.

Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.

Baumeister S, Wiesner J, Reichenberg A, Hintz M, Bietz S, Harb OS, Roos DS, Kordes M, Friesen J, Matuschewski K, Lingelbach K, Jomaa H, Seeber F.

PLoS One. 2011 May 4;6(5):e19334. doi: 10.1371/journal.pone.0019334.

14.

New targets for drug discovery against malaria.

Santos G, Torres NV.

PLoS One. 2013;8(3):e59968. doi: 10.1371/journal.pone.0059968. Epub 2013 Mar 28.

15.

In vitro and in vivo inhibition of erythrocytic development of malarial parasites by docetaxel.

Sinou V, Grellier P, Schrevel J.

Antimicrob Agents Chemother. 1996 Feb;40(2):358-61.

16.

Influence of paclitaxel on parasitemia and survival of Plasmodium berghei infected mice.

Koka S, Bobbala D, Lang C, Boini KM, Huber SM, Lang F.

Cell Physiol Biochem. 2009;23(1-3):191-8. doi: 10.1159/000204107. Epub 2009 Feb 18.

17.

Antimalarial and safety evaluation of Pluchea lanceolata (DC.) Oliv. & Hiern: in-vitro and in-vivo study.

Mohanty S, Srivastava P, Maurya AK, Cheema HS, Shanker K, Dhawan S, Darokar MP, Bawankule DU.

J Ethnopharmacol. 2013 Oct 7;149(3):797-802. doi: 10.1016/j.jep.2013.08.003. Epub 2013 Aug 14.

PMID:
23954323
18.

Curcumin for malaria therapy.

Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN.

Biochem Biophys Res Commun. 2005 Jan 14;326(2):472-4.

PMID:
15582601
19.

Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.

Guiguemde WA, Hunt NH, Guo J, Marciano A, Haynes RK, Clark J, Guy RK, Golenser J.

Antimicrob Agents Chemother. 2014 Aug;58(8):4745-54. doi: 10.1128/AAC.01553-13. Epub 2014 Jun 9.

20.

The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum.

Gelhaus C, Jacobs T, Andrä J, Leippe M.

Antimicrob Agents Chemother. 2008 May;52(5):1713-20. doi: 10.1128/AAC.01342-07. Epub 2008 Mar 10.

Supplemental Content

Support Center